Clinical Trial Update: Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery [Phase 2]

View source ↗

Summary

Phase 2 study assessing whether adding oral amisulpride to standard dual prophylaxis improves control of postoperative nausea and vomiting in high-risk gynecolo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Amisulpride (amisulpride)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Post Operative Nausea and Vomiting (PONV) | Phase 2 | Status: RECRUITING